1. Home
  2. ASMB vs BOOM Comparison

ASMB vs BOOM Comparison

Compare ASMB & BOOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • BOOM
  • Stock Information
  • Founded
  • ASMB 2005
  • BOOM 1965
  • Country
  • ASMB United States
  • BOOM United States
  • Employees
  • ASMB 73
  • BOOM N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • BOOM Industrial Specialties
  • Sector
  • ASMB Health Care
  • BOOM Industrials
  • Exchange
  • ASMB Nasdaq
  • BOOM Nasdaq
  • Market Cap
  • ASMB 198.6M
  • BOOM 128.2M
  • IPO Year
  • ASMB 2010
  • BOOM N/A
  • Fundamental
  • Price
  • ASMB $25.50
  • BOOM $6.31
  • Analyst Decision
  • ASMB Strong Buy
  • BOOM Hold
  • Analyst Count
  • ASMB 4
  • BOOM 1
  • Target Price
  • ASMB $38.67
  • BOOM $8.50
  • AVG Volume (30 Days)
  • ASMB 147.2K
  • BOOM 225.1K
  • Earning Date
  • ASMB 08-06-2025
  • BOOM 08-05-2025
  • Dividend Yield
  • ASMB N/A
  • BOOM N/A
  • EPS Growth
  • ASMB N/A
  • BOOM N/A
  • EPS
  • ASMB N/A
  • BOOM N/A
  • Revenue
  • ASMB $33,247,000.00
  • BOOM $619,580,000.00
  • Revenue This Year
  • ASMB $12.44
  • BOOM N/A
  • Revenue Next Year
  • ASMB N/A
  • BOOM $2.68
  • P/E Ratio
  • ASMB N/A
  • BOOM N/A
  • Revenue Growth
  • ASMB 54.77
  • BOOM N/A
  • 52 Week Low
  • ASMB $7.75
  • BOOM $5.78
  • 52 Week High
  • ASMB $27.17
  • BOOM $13.77
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 65.04
  • BOOM 38.89
  • Support Level
  • ASMB $24.98
  • BOOM $5.78
  • Resistance Level
  • ASMB $27.17
  • BOOM $7.04
  • Average True Range (ATR)
  • ASMB 1.13
  • BOOM 0.31
  • MACD
  • ASMB -0.06
  • BOOM 0.04
  • Stochastic Oscillator
  • ASMB 64.24
  • BOOM 27.72

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About BOOM DMC Global Inc.

DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.

Share on Social Networks: